Clin2
NCT03272698Possibly a fitRecruiting

Ketamine plus ECT versus higher-dose ketamine with rescue

Treatment Resistant DepressionKetamine

Treatments studied

Part of Mental health clinical trials.

This study compares two ways of using ketamine with ECT (electroconvulsive therapy) in people with treatment-resistant depression. It aims to find whether a higher-dose ketamine approach, with extra rescue measures, works better or more safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
62 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have depression that has not improved after at least 2 standard antidepressant medicines taken long enough
  • Your depression severity score (MADRS) is above 20, and ECT is planned
  • You can understand the study and sign informed consent
  • Your overall health status is not too high-risk for anesthesia (ASA score must be under 4)
  • You do not have certain heart, lung, stroke/brain blood vessel, pressure-in-brain/eye, or seizure-related problems that would make ECT unsafe
  • You do not have a device with electronic parts inside your body (like a pacemaker or deep brain stimulator), and you are not allergic to study drugs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07088380Recruiting· Phase 3
Ketamine combined with ECT for hard-to-treat depression

This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.

Milan
NCT06488586Recruiting
Ketamine vs Esketamine for treatment-resistant depression

This trial compares two forms of ketamine—given by IV or as a nasal spray—in people with major depression that hasn't improved after trying at least two other antidepressants. The goal is to see which treatment works better.

Kingston, Ontario
NCT06480201Recruiting· Phase 1
Ketamine for treatment-resistant depression: a brain wave study

This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.

Houston, Texas
NCT07706478Recruiting
Ketamine and Talk Therapy for Tough Depression

This trial tests whether a combination of ketamine (given through an IV) and talk therapy can help people with depression that hasn't responded to other treatments. If you have tried multiple antidepressants and therapy without success, this study may offer a new option.

Doorn, Utrecht
NCT06278779Recruiting· Phase 4
Comparing two types of ketamine for stubborn depression

This study compares two forms of ketamine to see which works better for depression that hasn't improved with at least two other antidepressants. If you've tried multiple antidepressants without success, this trial might help find a more effective treatment.

Camperdown, New South Wales
NCT06668571Recruiting· Phase 2
Ketamine for treatment-resistant depression

This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.

Rochester, Minnesota

Hear when a new Treatment Resistant Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.